UnitedHealth Group Incorporated· UNH
🇺🇸 US · LargeSP500NYSE
- Price
- $377.56
- Day
- +0.18%
- Mkt Cap
- $342.88B
- 52W Range
- $255.97 – $461.62
- Volume
- 4.97M
- Beta
- 0.62
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
UnitedHealth Group is experiencing a strong operational turnaround, with margin recovery in both UnitedHealthcare and Optum Health segments. UNH's Q2 results showed revenue of $112 billion, adjusted EPS of $6.38, and significant year-over-year margin improvements across key divisions. Management's cost controls, contract resets, and technology-driven efficiencies are driving sustainable margin expansion and earnings growth into 2027 and 2028.
Read full article
UnitedHealth's stock has been doing much better this year due to improved financial results. Costs have been coming down, and the company raised its guidance in July.
Read full article
eHealth says surging 2027 health costs are pushing smaller employers toward ICHRAs, potentially expanding individual coverage demand.
Read full article
Clinicians and staff gain an up-to-date view of capacity, patient movement, and environmental services workflows AUSTIN, Texas, Sept. 18, 2026 /PRNewswire/ -- San Juan Regional Medical Center has strengthened its clinical operations with several new Oracle Health solutions that help streamline patient flow, improve bed management, and enhance operational visibility.
Read full article
On CNBC's “Halftime Report Final Trades,” Kevin Simpson, founder and CEO of Capital Wealth Planning, picked UnitedHealth Group Incorporated (NYSE:UNH).
Read full article
I still view UnitedHealth as a fully playable recovery, with MCR improving from 89.4% to 86.7% and 2026 EPS guidance already raised twice. Management is deliberately giving up lower-quality membership to rebuild margins, while operating cash flow guidance has increased from >$18B to ~$24B. The broader health care setup also looks attractive, with the sector heavily lagging the S&P 500 and a more defensive macro backdrop developing.
Read full article
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read full article
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read full article
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read full article
On CNBC's “Halftime Report Final Trades,” Jenny Van Leeuwen Harrington, chief executive officer of Gilman Hill Asset Management, LLC, picked The Charles Schwab Corporation (NYSE:SCHW).
Read full article
The next quarterly UnitedHealth (NYSE: UNH) dividend is coming next week, on Tuesday, September 22, 2026, when all shareholders of record as of the close of business on September 14, 2026, will receive $2.32 per share.
Read full article
UnitedHealth Group (UNH) remains a buy, with attractive valuation and solid fundamentals despite recent underperformance versus the S&P 500. Q2 results delivered an earnings triple play: beats on revenue and EPS, plus raised FY 2026 guidance; medical loss ratio held at 86.7%. Consensus EPS upgrades (24 upgrades, zero downgrades) and a 6.9% FCF yield support confidence in UNH's long-term growth trajectory.
Read full article